Medtronic (MDT) is facing significant near-term pressure as short sellers aggressively target the medical device giant. Data from the FINRA Regulatory Short Sale (Reg SHO) filings pool reveals a stark divergence in trading behavior on October 5, 2026. The short-volume ratio for MDT spiked to 84.9% on that specific session, a massive departure from the 20-day average of 45.8%.
This extreme level of shorting is accompanied by a surge in activity. The total volume on that day reached 17.9 million shares, dwarfing the average of 4.09 million shares. The combination of an 84.9% short-volume ratio and a 4.4x volume increase signals that institutional investors are aggressively betting against the stock, likely anticipating specific negative catalysts or a broader downturn in the sector.
What would change this read
The bearish thesis relies entirely on the sustainability of this aggressive positioning; if the short-volume ratio for MDT drops back below the 20-day mean of 45.8% in the next session, it would suggest that the current wave of short selling is unwinding rather than continuing.
